Although the role of glucose transporters as markers of melanoma progression and the effect of BRAF inhibition on melanoma cell metabolism have been studied [4, 5, 30–35], the consequences of glucose deprivation on signalling networks key for melanoma biology have not been specifically addressed in the literature. The gene discussed is BRAF; the disease is melanoma.